Lake Street analyst Brooks O’Neil notes that Stryker (SYK) announced a definitive agreement for the sale of its U.S. spinal implants business ...

On Jan. 28, Stryker Corp. announced plans to sell its U.S. spinal implant business to investment firm Viscogliosi Brothers. Though Stryker has a major share in the U.S. spine and orthopedic market, ...

Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...

Beeline Labs, a new division of Eastside Distilling, launches BlinkQC, a QC solution for lenders that automates the process in 3 mins, saving time and money.

FY25 Outlook: Sirius XM expects revenue of $8.500 billion versus the consensus of $8.594 billion. It also projected an adjusted EBITDA of $2.60 billion and expects a free cash flow of $1.15 billion.

The Shareholders' Nomination Board of Bioretec Ltd ("Bioretec") has resolved to make the following proposals to the Annual General Meeting. The Annual General Meeting of Bioretec is scheduled to be ...

Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.

Truist raised the firm’s price target on Stryker (SYK) to $413 from $409 and keeps a Hold rating on the shares. The company remains a top-tier ...

By adopting this groundbreaking technology, Long Beach Medical Center reaffirms its commitment to providing the highest level ...

Private equity returns overtook those offered by private credit in the third quarter, according to data from State Street Corp., in what some see as a sign of a longer-term rebalancing between the two ...